Literature DB >> 25770841

Diabetes mellitus and atrial fibrillation: Pathophysiological mechanisms and potential upstream therapies.

Christos A Goudis1, Panagiotis Korantzopoulos2, Ioannis V Ntalas3, Eleftherios M Kallergis4, Tong Liu5, Dimitrios G Ketikoglou6.   

Abstract

Diabetes mellitus (DM) represents one of the most important risk factors for atrial fibrillation (AF) while AF is a strong and independent marker of overall mortality and cardiovascular morbidity in diabetic patients. Autonomic, electrical, electromechanical, and structural remodeling, including oxidative stress, connexin remodeling and glycemic fluctuations seem to be implicated in AF pathophysiology in the setting of DM. The present review highlights the association between DM and AF, provides a comprehensive overview of the responsible pathophysiological mechanisms and briefly discusses potential upstream therapies for DM-related atrial remodeling.
Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Atrial fibrillation; Atrial remodeling; Diabetes mellitus; Upstream therapies

Mesh：

Substances：

Year:  2015        PMID： 25770841     DOI： 10.1016/j.ijcard.2015.03.052

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN： 0167-5273            Impact factor:   4.164


  42 in total

Review 1.  Addressing Multimorbidity and Polypharmacy in Individuals With Atrial Fibrillation.

Authors:  Fahad Shaikh; Lachlan B Pasch; Phillip J Newton; Beata V Bajorek; Caleb Ferguson
Journal:  Curr Cardiol Rep       Date:  2018-03-24       Impact factor: 2.931

2.  2021 ISHNE/HRS/EHRA/APHRS Expert Collaborative Statement on mHealth in Arrhythmia Management: Digital Medical Tools for Heart Rhythm Professionals: From the International Society for Holter and Noninvasive Electrocardiology/Heart Rhythm Society/European Heart Rhythm Association/Asia-Pacific Heart Rhythm Society.

Authors:  Niraj Varma; Iwona Cygankiewicz; Mintu P Turakhia; Hein Heidbuchel; Yu-Feng Hu; Lin Yee Chen; Jean-Philippe Couderc; Edmond M Cronin; Jerry D Estep; Lars Grieten; Deirdre A Lane; Reena Mehra; Alex Page; Rod Passman; Jonathan P Piccini; Ewa Piotrowicz; Ryszard Piotrowicz; Pyotr G Platonov; Antonio Luiz Ribeiro; Robert E Rich; Andrea M Russo; David Slotwiner; Jonathan S Steinberg; Emma Svennberg
Journal:  Circ Arrhythm Electrophysiol       Date:  2021-02-12

3.  Impaired left atrial strain in the presence of interatrial block in patients with type 2 diabetes mellitus.

Authors:  Mustafa Dogdus; Ferhat Dindas; Onur Akhan; Mustafa Yenercag; Arafat Yildirim; Ozge Ozcan Abacioglu; Salih Kilic
Journal:  Int J Cardiovasc Imaging       Date:  2021-05-06       Impact factor: 2.357

4.  Role of diabetes and insulin use in the risk of stroke and acute myocardial infarction in patients with atrial fibrillation: A Medicare analysis.

Authors:  Amgad Mentias; Ghanshyam Shantha; Oluwaseun Adeola; Geoffrey D Barnes; Bharat Narasimhan; Konstantinos C Siontis; Deborah A Levine; Rajan Sah; Michael C Giudici; Mary Vaughan Sarrazin
Journal:  Am Heart J       Date:  2019-05-10       Impact factor: 4.749

5.  Association between insomnia and atrial fibrillation in a Chinese population: A cross-sectional study.

Authors:  Xu Han; Yiheng Yang; Yue Chen; Lianjun Gao; Xiaomeng Yin; Huihua Li; Jing Qiu; Youxin Wang; Yong Zhou; Yunlong Xia
Journal:  Clin Cardiol       Date:  2017-05-31       Impact factor: 2.882

Review 6.  Effect of antidiabetic drugs on the risk of atrial fibrillation: mechanistic insights from clinical evidence and translational studies.

Authors:  Ting-Wei Lee; Ting-I Lee; Yung-Kuo Lin; Yao-Chang Chen; Yu-Hsun Kao; Yi-Jen Chen
Journal:  Cell Mol Life Sci       Date:  2020-09-23       Impact factor: 9.261

7.  Thiazolidinediones and Risk of Atrial Fibrillation Among Patients with Diabetes and Coronary Disease.

Authors:  Jannik Langtved Pallisgaard; Maria Mori Brooks; Bernard R Chaitman; Derek B Boothroyd; Marco Perez; Mark A Hlatky
Journal:  Am J Med       Date:  2018-03-23       Impact factor: 4.965

8.  Severe hypoglycemia is a risk factor for atrial fibrillation in type 2 diabetes mellitus: Nationwide population-based cohort study.

Authors:  Seung-Hyun Ko; Yong-Moon Park; Jae-Seung Yun; Seon-Ah Cha; Eue-Keun Choi; Kyungdo Han; Eugene Han; Yong-Ho Lee; Yu-Bae Ahn
Journal:  J Diabetes Complications       Date:  2017-09-19       Impact factor: 2.852

Review 9.  Risk Factor Management in Atrial Fibrillation.

Authors:  Axel Brandes; Marcelle D Smit; Bao Oanh Nguyen; Michiel Rienstra; Isabelle C Van Gelder
Journal:  Arrhythm Electrophysiol Rev       Date:  2018-06

10.  Atrial Fibrillation (Part 1): Pathophysiology, Risk Factors, and Therapeutic Basis.

Authors:  Fatima Dumas Cintra; Marcio Jansen de Oliveira Figueiredo
Journal:  Arq Bras Cardiol       Date:  2021-01       Impact factor: 2.000
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.